Laser Assisted Liposuction
Conditions
Brief summary
Single-center, prospective, open-label study. The study aims to assess the structure and viability of fat collected during the LipoLife liposuction procedure
Interventions
DEVICELipoLife system
Abdominal Laser-Assisted Liposuction
Sponsors
Alma Lasers
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes
Inclusion criteria
1. Subjects scheduled to undergo abdominal w/wo flanks laser-assisted liposuction surgery and are willing to donate the harvested adipose tissue for the study assessment. 2. Between 18 and 70 years of age. 3. Estimated fat harvesting of at least 300 milliliters. 4. Provided written Informed Consent.
Exclusion criteria
1. Pregnant or intending to become pregnant during the course of study. 2. Current smoker. 3. Presence of known malignancy. 4. Active infection in the treatment area. 5. History of autoimmune disorder (e.g., Systemic Lupus Erythematosus \[SLE\]). 6. History of connective, metabolic, or atrophic skin disease. 7. History of keloid scarring. 8. Chronic use (\>7 consecutive days) of anticoagulants (such as aspirin) or NSAIDs within 15 days before enrollment. 9. Subjects with immune system diseases. 10. Any other reason that in the opinion of the investigator, prevents the subject from participating in the study or compromises the subject safety.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Average adipose cell cluster size | 6 months | Assessment of adipose cell cluster size by microscope |
Countries
United States
Outcome results
None listed